Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease

Sherrie J. Divito(Brigham and Women's Hospital), Thomas S. Kupper(Harvard University), Rachael A. Clark(Brigham and Women's Hospital), Jude Hilaire, John T. O’Malley(Sanofi (United States)), Henrik M. Reims(Oslo University Hospital), Martín C. Mihm, Corey Cutler(Dana-Farber Cancer Institute), Vincent T. Ho(Dana-Farber Cancer Institute), Matthew Collin(National Institute for Health and Care Research), Haesook T. Kim(Dana-Farber Cancer Institute), Pei‐Chen Hsieh(Brigham and Women's Hospital), Frode L. Jahnsen(Oslo University Hospital), Christopher P. Elco(Brown University), Tobias Gedde‐Dahl, Espen S. Bækkevold(Oslo University Hospital), Robert J. Soiffer(Dana-Farber Cancer Institute), Anders Theodor Aasebo(Oslo University Hospital), Tiago R. Matos(Sanofi (Netherlands)), Michael Hagerstrom, Indira Guleria(Brigham and Women's Hospital), Edgar L. Milford(Brigham and Women's Hospital), Jerome Ritz(Harvard University), Geraldine S. Pinkus(Brigham and Women's Hospital), John W. Lian(Brigham and Women's Hospital)
Journal of Clinical Investigation
June 9, 2020
Cited by 86


Related Papers